![](/img/cover-not-exists.png)
SAFETY AND EFFICACY 31 WEEK DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-MODERATE ALZHEIMER’S DISEASE PATIENTS
Macfarlane, Stephen, Cecchi, Marco, Moore, Dennis, Maruff, Paul, Zografidis, Tasos, Missling, ChristopherVolume:
12
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2016.07.101
Date:
July, 2016
File:
PDF, 47 KB
english, 2016